Zetia claims win magistrate blessing

Glenmark Pharmaceuticals and Merck should have to face pay-for-delay claims over the cholesterol-lowering drug Zetia at trial, a federal magistrate judge has said.

Unlock unlimited access to all Global Competition Review content